ctrlnum article-5600
fullrecord <?xml version="1.0"?> <dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><title lang="en-US">Sodium Benzoate is Associated with Salmonella typhi Resistant to Chloramphenicol</title><creator>Jonny K Fajar; Medical Research Unit, Faculty of Medicine, Universitas Syiah Kuala, Darussalam, Banda Aceh 23111</creator><creator>Retno A Puspitasari; School of Medicine, Islamic University of Malang, Malang 65144</creator><creator>Ariani R Dewi; Departmen of Ophthalmology, School of Medicine, Islamic University of Malang, Malang 65144</creator><creator>Arif Yahya; Medical Research Unit, Scholl of Medicine, Islamic University of Malang, Malang 65144</creator><creator>Jay R Anand; Departmen of Pharmacology, National Institute of Pharmaceutical Education and Research, Guwahati, Assam 781006</creator><subject lang="en-US"/><subject lang="en-US">Salmonella typhi; chloramphenicol; sodium benzoate; drug resistance</subject><description lang="en-US">Objective:Objective: There are many factors that govern growth and resistant of Salmonella typhi. A study had reported that the use of sodium benzoate caused antibiotic resistant. However, no study has directly evaluated the effect of sodium benzoate exposure on S. typhi sensitivity to chloramphenicol. The aim of this study was to evaluate the resistance or sensitivity of S. typhi to chloramphenicol after sodium benzoate exposure. Methods: The study was conducted in seven groups: three treatment groups (sodium benzoate insensitive S. typhi+8 &amp;micro;g/mL, 16 &amp;micro;g/mL, and 32 &amp;micro;g/mL of chloramphenicol), three positive control groups (sodium benzoate sensitive S. typhi+8 &amp;micro;g/mL, 16 &amp;micro;g/mL, and 32 &amp;micro;g/mL of chloramphenicol), and one negative control groups (sodium benzoate sensitive S. typhi+0 &amp;micro;g/mL of chloramphenicol). The effect of sodium benzoate exposure to S. typhi sensitivity to chloramphenicol was measured after 24 hours. Spearman test was used to analyzed this association. Results: In this study, we found that the average S. typhi growth in the treatment groups (A, B, C) was 445 CFU/mL, 385 CFU/mL, and 171 CFU/mL, respectively. While in the positive control group (D, E, F) was not obtained any S. typhi growth. Average S. typhi growth in the negative control group was 430 CFU/mL. We found that sodium benzoate exposure inhibited S. typhi growth and affected S. typhi sensitivity to chloramphenicol (p&amp;lt;0.05). In addition, we found that 32 &amp;micro;g/mL chloramphenicol had the highest mean difference value, so this showed that the dose 32 &amp;micro;g/mL of chloramphenicol had the best effectiveness of various treatment groups (p&amp;lt;0.05). Conclusions: Sodium benzoate exposure can inhibit S. typhi growth and cause S. typhi resistant to chloramphenicol.</description><publisher lang="en-US">Directorate of Research and Public Services Universitas Indonesia</publisher><contributor lang="en-US"/><date>2016-04-13</date><type>Other:</type><type>Other:</type><type>File:application/pdf</type><identifier>http://journal.ui.ac.id/index.php/health/article/view/5600</identifier><source lang="en-US">Makara Journal of Health Research; Vol 20, No 1 (2016): April; 1-5</source><language>eng</language><rights> Journal Publishing Agreement (JPA)&amp;nbsp;Makara Journal of Health Research (MJHR) &amp;nbsp;Your written acceptance of this JPA is required before the article can be published. MJHR reserves all rights to the published scientific manuscript. Please read this form carefully and sign it if you agree to its terms. The signed JPA should be sent to editor_msk@ui.ac.id. &amp;nbsp;AuthorshipAs the corresponding author, I certify on behalf of all of the authors that:The article is an original work and does not involve fraud, fabrication, or plagiarism.The article has not been published previously and is not currently under consideration for &#x2028;publication elsewhere. If accepted by MJHR, the article will not be submitted for publication in any &#x2028;other journal.The article contains no libelous or other unlawful statements and does not include any materials &#x2028;that infringe on individual privacy or proprietary rights or any statutory copyright.I have obtained written permission from copyright owners for any excerpts from copyrighted &#x2028;works that are included and have credited the sources in my article.All authors have made significant contributions to the study including the conception and design &#x2028;of this work, the analysis of the data, and the writing of the manuscript.All authors have reviewed this manuscript and take responsibility for its content and approve its &#x2028;publication.I have informed all of the authors of the terms of this publishing agreement, and I am signing on &#x2028;their behalf as their agent.Copyright Transfer AgreementI hereby assign and transfer to MJHR all exclusive rights of copyright ownership to the bellow mentioned work, including but not limited to the right to publish, republish, derivate, distribute, transmit, sell, and otherwise use the work and other related material worldwide, in whole or in part, in all languages, in electronic, printed, or any other forms of media now known or hereafter developed and the right to authorize or license third parties to do any of the above. I understand that these exclusive rights will become the property of MJHR, from the date the article is accepted for publication. I also understand that MJHR as a copyright owner has sole authority to license and permit reproductions of the article. I understand that except for copyright, other proprietary rights related to the Work (e.g. patent or other rights to any process or procedure) shall be retained by the authors. To reproduce any text, figures, tables, or illustrations from this work in future works of their own, the authors must obtain written permission from MJHR; such approval cannot be unreasonably withheld by MJHR.Conflict of Interest DisclosureI confirm that all funding sources supporting the work and all institutions or people who contributed to the work but who do not meet the criteria for authors are acknowledged. I also confirm that all commercial affiliations, stock ownership, equity interests, or patent-licensing arrangements that could be considered to pose a financial conflict of interest in connection with the article have been disclosed. </rights><recordID>article-5600</recordID></dc>
language eng
format Other:
Other
File:application/pdf
File
Journal:eJournal
Journal
author Jonny K Fajar; Medical Research Unit, Faculty of Medicine, Universitas Syiah Kuala, Darussalam, Banda Aceh 23111
Retno A Puspitasari; School of Medicine, Islamic University of Malang, Malang 65144
Ariani R Dewi; Departmen of Ophthalmology, School of Medicine, Islamic University of Malang, Malang 65144
Arif Yahya; Medical Research Unit, Scholl of Medicine, Islamic University of Malang, Malang 65144
Jay R Anand; Departmen of Pharmacology, National Institute of Pharmaceutical Education and Research, Guwahati, Assam 781006
title Sodium Benzoate is Associated with Salmonella typhi Resistant to Chloramphenicol
publisher Directorate of Research and Public Services Universitas Indonesia
publishDate 2016
topic Salmonella typhi
chloramphenicol
sodium benzoate
drug resistance
url http://journal.ui.ac.id/index.php/health/article/view/5600
contents Objective:Objective: There are many factors that govern growth and resistant of Salmonella typhi. A study had reported that the use of sodium benzoate caused antibiotic resistant. However, no study has directly evaluated the effect of sodium benzoate exposure on S. typhi sensitivity to chloramphenicol. The aim of this study was to evaluate the resistance or sensitivity of S. typhi to chloramphenicol after sodium benzoate exposure. Methods: The study was conducted in seven groups: three treatment groups (sodium benzoate insensitive S. typhi+8 &micro;g/mL, 16 &micro;g/mL, and 32 &micro;g/mL of chloramphenicol), three positive control groups (sodium benzoate sensitive S. typhi+8 &micro;g/mL, 16 &micro;g/mL, and 32 &micro;g/mL of chloramphenicol), and one negative control groups (sodium benzoate sensitive S. typhi+0 &micro;g/mL of chloramphenicol). The effect of sodium benzoate exposure to S. typhi sensitivity to chloramphenicol was measured after 24 hours. Spearman test was used to analyzed this association. Results: In this study, we found that the average S. typhi growth in the treatment groups (A, B, C) was 445 CFU/mL, 385 CFU/mL, and 171 CFU/mL, respectively. While in the positive control group (D, E, F) was not obtained any S. typhi growth. Average S. typhi growth in the negative control group was 430 CFU/mL. We found that sodium benzoate exposure inhibited S. typhi growth and affected S. typhi sensitivity to chloramphenicol (p&lt;0.05). In addition, we found that 32 &micro;g/mL chloramphenicol had the highest mean difference value, so this showed that the dose 32 &micro;g/mL of chloramphenicol had the best effectiveness of various treatment groups (p&lt;0.05). Conclusions: Sodium benzoate exposure can inhibit S. typhi growth and cause S. typhi resistant to chloramphenicol.
id IOS2205.article-5600
institution Universitas Indonesia
institution_id 51
institution_type library:university
library
library Perpustakaan Universitas Indonesia
library_id 492
collection MAKARA of Health Series
repository_id 2205
subject_area Kesehatan dan Kedokteran
city KOTA DEPOK
province JAWA BARAT
repoId IOS2205
first_indexed 2016-09-24T00:13:44Z
last_indexed 2016-09-24T00:20:25Z
recordtype dc
_version_ 1685768608621264896
score 17.607244